We employ state of the art technologies for our studies. Our germ-free facility, metagenomic next-generation sequencing and analysis platforms, and robotic high-throughput modalities enable the in-depth elucidation of the molecular and genetic mechanisms underlying host-microbial interactions in the in-vivo setting.

In addition, we use novel transgenic mice in a multitude of animal models for human disease. Using a combination of these technologies, we aim at deciphering the molecular "language" of communication between the host and the microbiota in order to exploit this language for the development of personalized approaches to treating common idiopathic diseases.